Intermediates of neutral endopeptidase inhibitors and preparation method thereof

US9278908B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9278908-B2
Application numberUS-201514739172-A
CountryUS
Kind codeB2
Filing dateJun 15, 2015
Priority dateJan 22, 2010
Publication dateMar 8, 2016
Grant dateMar 8, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a new process for producing useful intermediates for the manufacture of NEP inhibitors or prodrugs thereof, in particular NEP inhibitors comprising a g-amino-d-biphenyl-a-methylalkanoic acid, or acid ester, backbone, such as N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester or salt thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for preparing N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester, or a salt thereof, or the compound N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid comprising i) reacting a compound of formula (3), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group; first with a base and then with a compound of the formula CO 2 or R4COY, wherein Y is halogen or —OR′ and wherein R4 and R′ are independently selected from alkyl, aryl and arylalkyl, to obtain a compound of formula (4), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group; and R4 is selected from hydroxyl, alkyl, aryl and arylalkyl; and ii) reacting the obtained compound of formula (4), or salt thereof, with a base and formaldehyde, optionally in the presence of a phase transfer catalyst, to obtain a compound of formula (1), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group; and iii) subsequently converting the obtained compound of formula (1) to the compound N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester, or a salt thereof, or the compound N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid or a salt thereof. 2. The process according to claim 1 , wherein R4 is hydroxyl and wherein the compound of formula (3) is reacted first with a base and then with a compound of the formula CO 2 . 3. The process according to claim 1 , wherein R4 is selected from alkyl, aryl and arylalkyl and wherein the compound of formula (3) is reacted first with a base and then with a compound of the formula R4COY, wherein Y is halogen or —OR′ and wherein R4 and R′ are independently selected from alkyl, aryl and arylalkyl. 4. The process according to claim 1 , wherein the base in step i) is selected from a metal hydride; an alkali metal alkoxide; an amine, optionally in the presence of an additive selected from an alkaline earth metal halide; a base of the formula MRa, wherein M is an alkali metal and Ra is alkyl or aryl; a base of the formula RcRdNM, wherein Rc and Rd are independently selected from alkyl, cycloalkyl, heterocyclyl and silyl and M is an alkali metal; and mixtures thereof. 5. The process according to claim 1 , wherein the base in step ii) is selected from a metal hydride; an amine; an inorganic base; a base of the formula MRa, wherein M is an alkali metal and Ra is alkyl or aryl; a base of the formula RcRdNM, wherein Rc and Rd are independently selected from alkyl, cycloalkyl, heterocyclyl and silyl and M is an alkali metal; and mixtures thereof. 6. The process according to claim 5 , wherein the reaction further comprises adding an alkali metal salt and optionally a drying agent. 7. The process according to claim 1 , wherein steps i) and ii) take place via one-pot. 8. The process according to claim 1 , wherein R1 is selected from t-butoxycarbonyl, benzoyl, styryl, 1-butenyl, benzyl, p-methoxybenzyl and pyrrolidinylmethyl; and R4 is selected from t-butyl, methyl, isopropyl, phenyl and hydroxyl. 9. A process according to claim 1 , wherein the compound of formula (4) is of the formula (4a) (4a) wherein R1 and R4 are as defined for the compound of formula (4). 10. A process according to claim 1 , wherein the compound of formula (3) is of the formula (3a) wherein R1 is as defined for the compound of formula (3). 11. A process according to claim 1 , wherein the compound of formula (1) is of the formula (1a) wherein R1 is as defined for the compound of formula (1).

Assignees

Inventors

Classifications

  • with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom · CPC title

  • 2-Pyrrolidones · CPC title

  • Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • C07C231/10Primary

    from compounds not provided for in groups C07C231/02 - C07C231/08 · CPC title

  • 2-Pyrrolones · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9278908B2 cover?
The invention relates to a new process for producing useful intermediates for the manufacture of NEP inhibitors or prodrugs thereof, in particular NEP inhibitors comprising a g-amino-d-biphenyl-a-methylalkanoic acid, or acid ester, backbone, such as N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester or salt thereof.
Who is the assignee on this patent?
Hook David, Zhou Jianguang, Li Yunzhong, and 2 more
What technology area does this patent fall under?
Primary CPC classification C07C231/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).